Literature DB >> 7598762

Novel pattern of P53 mutation in breast cancers from Austrian women.

A Hartmann1, G Rosanelli, H Blaszyk, J M Cunningham, R M McGovern, J J Schroeder, D J Schaid, J S Kovach, S S Sommer.   

Abstract

Since mutagens produce an extraordinary diversity of mutational patterns, differential mutational exposures among populations are expected to produce different patterns of mutation. Classical epidemiological methods have been successful in implicating specific mutagens in cancers such as those of lung and skin in which one mutagen predominates. In breast cancer, however, no mutagens have been implicated in an unequivocal manner. In an attempt to facilitate epidemiological studies, we have been studying the pattern of p53 gene mutations in breast cancers from multiple populations with high and low breast cancer incidences. We previously reported that breast cancers from Midwest United States, predominantly rural Caucasian women, have a different pattern of p53 gene mutation from populations of Western European women. Herein, we analyze patterns of p53 mutations from Graz, Austria, another population with a high incidence of breast cancer. Among the 60 Austrian breast cancers analyzed, 14 (23%) have a p53 gene mutation in exons 5-9 or in adjacent splice junctions. Analysis of the patterns of mutation shows differences between the "Western European" profile and the Austrian and Midwest United States groups (P = 0.027 and 0.024, respectively). The Austrian pattern is characterized by a high frequency of A:T-->T:A transversions (P = 0.006). The presence of distinct patterns of mutation among the limited number of analyzed populations of Western European origin supports the idea that differential mutagenic exposure and/or genetic differences contribute to breast cancer mutagenesis among geographically distinct Caucasians of Western European origin.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7598762      PMCID: PMC295535          DOI: 10.1172/JCI117714

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  28 in total

Review 1.  Molecular epidemiology and the genetics of environmental cancer.

Authors:  P G Shields; C C Harris
Journal:  JAMA       Date:  1991-08-07       Impact factor: 56.272

2.  Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa.

Authors:  B Bressac; M Kew; J Wands; M Ozturk
Journal:  Nature       Date:  1991-04-04       Impact factor: 49.962

3.  Cancer statistics, 1993.

Authors:  C C Boring; T S Squires; T Tong
Journal:  CA Cancer J Clin       Date:  1993 Jan-Feb       Impact factor: 508.702

Review 4.  Assessing the underlying pattern of human germline mutations: lessons from the factor IX gene.

Authors:  S S Sommer
Journal:  FASEB J       Date:  1992-07       Impact factor: 5.191

5.  Direct sequencing from touch preparations of human carcinomas: analysis of p53 mutations in breast carcinomas.

Authors:  J S Kovach; R M McGovern; J D Cassady; S K Swanson; L E Wold; B Vogelstein; S S Sommer
Journal:  J Natl Cancer Inst       Date:  1991-07-17       Impact factor: 13.506

6.  p53 mutations occur in aggressive breast cancer.

Authors:  R Mazars; L Spinardi; M BenCheikh; J Simony-Lafontaine; P Jeanteur; C Theillet
Journal:  Cancer Res       Date:  1992-07-15       Impact factor: 12.701

7.  p53 gene mutations in human epithelial skin cancers.

Authors:  J P Molès; C Moyret; B Guillot; P Jeanteur; J J Guilhou; C Theillet; N Basset-Sèguin
Journal:  Oncogene       Date:  1993-03       Impact factor: 9.867

8.  p53 mutations in breast cancer.

Authors:  C Coles; A Condie; U Chetty; C M Steel; H J Evans; J Prosser
Journal:  Cancer Res       Date:  1992-10-01       Impact factor: 12.701

Review 9.  The pathology of breast cancer in Japanese women compared to other ethnic groups: a review.

Authors:  G N Stemmermann
Journal:  Breast Cancer Res Treat       Date:  1991-05       Impact factor: 4.872

10.  Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County.

Authors:  H Shimizu; R K Ross; L Bernstein; R Yatani; B E Henderson; T M Mack
Journal:  Br J Cancer       Date:  1991-06       Impact factor: 7.640

View more
  6 in total

1.  Database of p53 gene somatic mutations in human tumors and cell lines: updated compilation and future prospects.

Authors:  P Hainaut; T Soussi; B Shomer; M Hollstein; M Greenblatt; E Hovig; C C Harris; R Montesano
Journal:  Nucleic Acids Res       Date:  1997-01-01       Impact factor: 16.971

2.  HER2, TOP2A, CCND1, EGFR and C-MYC oncogene amplification in colorectal cancer.

Authors:  Khawla Al-Kuraya; Hedvika Novotny; Prashant Bavi; Abdul K Siraj; Shahab Uddin; Adnan Ezzat; Nasser Al Sanea; Fouad Al-Dayel; Hadeel Al-Mana; Salwa S Sheikh; Martina Mirlacher; Coya Tapia; Ronald Simon; Guido Sauter; Luigi Terracciano; Luigi Tornillo
Journal:  J Clin Pathol       Date:  2006-08-01       Impact factor: 3.411

3.  P53 mutations associated with breast, colorectal, liver, lung, and ovarian cancers.

Authors:  T Lasky; E Silbergeld
Journal:  Environ Health Perspect       Date:  1996-12       Impact factor: 9.031

4.  Transcriptomics profiling study of breast cancer from Kingdom of Saudi Arabia revealed altered expression of Adiponectin and Fatty Acid Binding Protein4: Is lipid metabolism associated with breast cancer?

Authors:  Adnan Merdad; Sajjad Karim; Hans-Juergen Schulten; Manikandan Jayapal; Ashraf Dallol; Abdelbaset Buhmeida; Fatima Al-Thubaity; Mamdooh A GariI; Adeel G A Chaudhary; Adel M Abuzenadah; Mohammed H Al-Qahtani
Journal:  BMC Genomics       Date:  2015-01-15       Impact factor: 3.969

5.  Low expression of leptin and its association with breast cancer: A transcriptomic study.

Authors:  Sajjad Karim; Adnan Merdad; Hans-Juergen Schulten; Manikandan Jayapal; Ashraf Dallol; Abdelbaset Buhmeida; Fatima Al-Thubaity; Zeenat Mirza; Mamdooh A Gari; Adeel G Chaudhary; Adel M Abuzenadah; Mohammed H Al-Qahtani
Journal:  Oncol Rep       Date:  2016-05-13       Impact factor: 3.906

6.  High frequency of p53 gene mutations in primary breast cancers in Japanese women, a low-incidence population.

Authors:  A Hartmann; H Blaszyk; S Saitoh; K Tsushima; Y Tamura; J M Cunningham; R M McGovern; J J Schroeder; S S Sommer; J S Kovach
Journal:  Br J Cancer       Date:  1996-04       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.